173 related articles for article (PubMed ID: 33801562)
21. Catecholamine response to exercise in patients with non-obstructive hypertrophic cardiomyopathy.
Shah AB; Bechis MZ; Brown M; Finch JM; Loomer G; Groezinger E; Weiner RB; Wasfy MM; Picard MH; Fifer MA; Lewis GB; Baggish AL
J Physiol; 2019 Mar; 597(5):1337-1346. PubMed ID: 30552684
[TBL] [Abstract][Full Text] [Related]
22. Cardiopulmonary Exercise Test in Patients with Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis.
Bayonas-Ruiz A; Muñoz-Franco FM; Ferrer V; Pérez-Caballero C; Sabater-Molina M; Tomé-Esteban MT; Bonacasa B
J Clin Med; 2021 May; 10(11):. PubMed ID: 34070695
[TBL] [Abstract][Full Text] [Related]
23. Validation of the 2014 European Society of Cardiology guidelines risk prediction model for the primary prevention of sudden cardiac death in hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; Liebregts M; Theuns DA; van Cleemput J; Ten Cate FJ; Willems R; Michels M
Circ Arrhythm Electrophysiol; 2015 Aug; 8(4):829-35. PubMed ID: 25922410
[TBL] [Abstract][Full Text] [Related]
24. The usefulness of sST2 and galectin-3 as novel biomarkers for better risk stratification in hypertrophic cardiomyopathy.
Gawor M; Śpiewak M; Janas J; Kożuch K; Wróbel A; Mazurkiewicz Ł; Baranowski R; Marczak M; Grzybowski J
Kardiol Pol; 2017; 75(10):997-1004. PubMed ID: 28612913
[TBL] [Abstract][Full Text] [Related]
25. The role of exercise testing in the evaluation of the patient with hypertrophic cardiomyopathy.
Firoozi S; Sharma S; McKenna WJ
Curr Cardiol Rep; 2001 Mar; 3(2):152-9. PubMed ID: 11177674
[TBL] [Abstract][Full Text] [Related]
26. The prognostic value of peak oxygen uptake in obstructive hypertrophic cardiomyopathy: A literature review to inform economic model development.
Butzner M; Kinyik-Merena C; Aguiar M; Davison N; Shreay S; Masri A
J Med Econ; 2024 Jun; ():1-14. PubMed ID: 38868944
[TBL] [Abstract][Full Text] [Related]
27. Impact of adverse left ventricular remodeling on sudden cardiac death in patients with hypertrophic cardiomyopathy.
Vriesendorp PA; Schinkel AF; de Groot NM; van Domburg RT; Ten Cate FJ; Michels M
Clin Cardiol; 2014 Aug; 37(8):493-8. PubMed ID: 25044226
[TBL] [Abstract][Full Text] [Related]
28. [Predicting value of 2014 European guidelines risk prediction model for sudden cardiac death (HCM Risk-SCD) in Chinese patients with hypertrophic cardiomyopathy].
Li WX; Liu LW; Wang J; Zuo L; Yang F; Kang N; Lei CH
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Dec; 45(12):1033-1038. PubMed ID: 29325362
[No Abstract] [Full Text] [Related]
29. Utility of metabolic exercise testing in distinguishing hypertrophic cardiomyopathy from physiologic left ventricular hypertrophy in athletes.
Sharma S; Elliott PM; Whyte G; Mahon N; Virdee MS; Mist B; McKenna WJ
J Am Coll Cardiol; 2000 Sep; 36(3):864-70. PubMed ID: 10987612
[TBL] [Abstract][Full Text] [Related]
30. Clinical significance of new-onset atrial fibrillation in patients with hypertrophic cardiomyopathy.
Kubo T; Baba Y; Ochi Y; Hirota T; Yamasaki N; Kawai K; Yamamoto K; Kondo F; Bando K; Yamada E; Furuno T; Yabe T; Doi YL; Kitaoka H
ESC Heart Fail; 2021 Dec; 8(6):5022-5030. PubMed ID: 34472710
[TBL] [Abstract][Full Text] [Related]
31. Validation of the new American College of Cardiology/American Heart Association Guidelines for the risk stratification of sudden cardiac death in a large Mediterranean cohort with Hypertrophic Cardiomyopathy.
Zegkos T; Tziomalos G; Parcharidou D; Ntelios D; Papanastasiou CA; Karagiannidis E; Gossios T; Rouskas P; Katranas S; Paraskevaidis S; Karvounis H; Efthimiadis G
Hellenic J Cardiol; 2022; 63():15-21. PubMed ID: 34147674
[TBL] [Abstract][Full Text] [Related]
32. Exercise capacity in hypertrophic cardiomyopathy. Role of stroke volume limitation, heart rate, and diastolic filling characteristics.
Lele SS; Thomson HL; Seo H; Belenkie I; McKenna WJ; Frenneaux MP
Circulation; 1995 Nov; 92(10):2886-94. PubMed ID: 7586256
[TBL] [Abstract][Full Text] [Related]
33. Left Atrial Myopathy is Associated With Exercise Incapacity and Ventilatory Inefficiency in Hypertrophic Cardiomyopathy.
Zegkos T; Kamperidis V; Ntelios D; Gossios T; Parcharidou D; Tziomalos G; Papanastasiou CA; Boutou AΚ; Katranas S; Rouskas P; Karamitsos T; Giannakoulas G; Karvounis H; Efthimiadis G
Heart Lung Circ; 2023 Feb; 32(2):215-223. PubMed ID: 36404220
[TBL] [Abstract][Full Text] [Related]
34. Sudden cardiac death in childhood hypertrophic cardiomyopathy is best predicted by a combination of electrocardiogram risk-score and HCMRisk-Kids score.
Östman-Smith I; Sjöberg G; Alenius Dahlqvist J; Larsson P; Fernlund E
Acta Paediatr; 2021 Nov; 110(11):3105-3115. PubMed ID: 34314540
[TBL] [Abstract][Full Text] [Related]
35. Left ventricular diastolic function assessed with cardiovascular magnetic resonance imaging and exercise capacity in patients with non-obstructive hypertrophic cardiomyopathy.
Małek LA; Chojnowska L; Kłopotowski M; Misko J; Dabrowski M; Kuśmierczyk-Droszcz B; Maczyńska R; Piotrowicz E; Ruzyłło W
Kardiol Pol; 2009 Jan; 67(1):1-6; discussion 7-8. PubMed ID: 19253184
[TBL] [Abstract][Full Text] [Related]
36. Characteristics and clinical significance of late gadolinium enhancement by contrast-enhanced magnetic resonance imaging in patients with hypertrophic cardiomyopathy.
Rubinshtein R; Glockner JF; Ommen SR; Araoz PA; Ackerman MJ; Sorajja P; Bos JM; Tajik AJ; Valeti US; Nishimura RA; Gersh BJ
Circ Heart Fail; 2010 Jan; 3(1):51-8. PubMed ID: 19850699
[TBL] [Abstract][Full Text] [Related]
37. Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
Lee HJ; Kim HK; Lee SC; Ommen SR; Kim J; Park JB; Choi YJ; Lee SP; Chang SA; Kim YJ
PLoS One; 2022; 17(2):e0264580. PubMed ID: 35213653
[TBL] [Abstract][Full Text] [Related]
38. Sudden cardiac death: investigation of the classical risk factors in a community-based hypertrophic cardiomyopathy cohort.
Anastasakis A; Theopistou A; Rigopoulos A; Kotsiopoulou C; Georgopoulos S; Fragakis K; Sevdalis E; Stefanadis C
Hellenic J Cardiol; 2013; 54(4):281-8. PubMed ID: 23912920
[TBL] [Abstract][Full Text] [Related]
39. Long-term Outcomes of Pediatric-Onset Hypertrophic Cardiomyopathy and Age-Specific Risk Factors for Lethal Arrhythmic Events.
Maurizi N; Passantino S; Spaziani G; Girolami F; Arretini A; Targetti M; Pollini I; Tomberli A; Pradella S; Calabri GB; Vinattieri V; Bertaccini B; Leone O; De Simone L; Rapezzi C; Marchionni N; Cecchi F; Favilli S; Olivotto I
JAMA Cardiol; 2018 Jun; 3(6):520-525. PubMed ID: 29710196
[TBL] [Abstract][Full Text] [Related]
40. Prognostic relevance of exercise testing in hypertrophic cardiomyopathy. A systematic review.
Rodrigues T; Raposo SC; Brito D; Lopes LR
Int J Cardiol; 2021 Sep; 339():83-92. PubMed ID: 34214502
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
